J2P-MC-LXBD icon

J2P-MC-LXBD

Medable Inc.
Free
0+ downloads

About J2P-MC-LXBD

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.

J2P-MC-LXBD Screenshots